Loading...
XKRX
090370
Market cap25mUSD
Dec 05, Last price  
1,490.00KRW
1D
2.97%
1Q
16.50%
Jan 2017
-92.85%
IPO
-99.34%
Name

MetaLabs Co Ltd

Chart & Performance

D1W1MN
XKRX:090370 chart
P/E
188.40
P/S
0.97
EPS
7.91
Div Yield, %
—
Shrs. gr., 5y
20.16%
Rev. gr., 5y
-15.09%
Revenues
38.36b
+77.60%
96,691,754,000115,633,244,000127,014,045,000124,493,331,000151,702,804,810145,623,074,000141,412,155,020127,864,761,590115,996,783,08092,066,961,94026,832,431,61047,375,133,98086,896,351,29083,353,809,65039,300,730,76022,659,042,21021,598,887,65038,359,458,000
Net income
197m
P
11,167,976,0001,701,550,000-4,123,168,000-2,350,432,000478,478,000-26,417,144,000-11,079,980,270-4,037,119,140-36,710,092,120-39,219,756,780-37,939,377,530-13,521,275,940-25,362,334,390-19,340,233,270-16,200,774,560-12,812,632,080-7,299,953,580196,936,000
CFO
-3.83b
L+7,621.02%
-1,559,379,000-335,133,000-13,404,655,0002,222,974,000-4,021,706,910-8,870,478,8002,567,033,290-10,838,135,350-7,883,383,220-10,014,767,330-8,468,021,080-6,896,735,860-4,021,331,0201,363,610,6202,279,490,380447,640,150-49,571,895-3,827,454,000
Dividend
Dec 27, 201227.309 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Metalabs Co., Ltd. primarily provides clothing in South Korea. It also manufactures and distributes prescription drugs, medical devices, and masks; develops peptide-based bio products; offers medical management services; and distributes cosmetics, as well as operates dating applications. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.
URL
http://www.metalabs.co.kr/
IPO date
Dec 26, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT